-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIDGEBIO ONCOLOGY THERAPEUTICS INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING: TARGET PRICE $25

Reuters·09/17/2025 10:19:34

Please log in to view news